Product Details

Veratoc-C Capsules combine three complementary cardiovascular agents in a single, convenient formulation for the secondary prevention of atherothrombotic events. Specifically, each capsule delivers Atorvastatin, Clopidogrel, and Aspirin at their standard maintenance doses. As a result, it offers simplified, combined lipid-lowering and antiplatelet therapy for patients with established cardiovascular disease.

The capsules combine:

• Atorvastatin Calcium IP (equivalent to Atorvastatin 40mg) – An HMG-CoA reductase inhibitor that blocks cholesterol synthesis in the liver. Consequently, it lowers LDL cholesterol and stabilizes atherosclerotic plaques, reducing cardiovascular risk.
• Clopidogrel Bisulfate IP (equivalent to Clopidogrel 75mg) – A P2Y12 receptor antagonist that inhibits ADP-induced platelet aggregation. As a result, it reduces the risk of thrombotic events such as heart attack and stroke.
• Aspirin IP (75mg) – A cyclooxygenase (COX) inhibitor that irreversibly blocks thromboxane A2 production in platelets. Consequently, it provides additional antiplatelet effect, complementing Clopidogrel’s mechanism for broader thrombotic protection.

Physicians prescribe Veratoc-C for patients with established coronary artery disease, prior myocardial infarction, or stroke, where combined lipid management and dual antiplatelet therapy are indicated. In addition, its single-capsule format simplifies the medication regimen and supports better patient adherence compared to taking three separate tablets. Because of this profile, Veratoc-C suits cardiology practices and secondary prevention programs managing patients at high cardiovascular risk.

Key Features:

• Overall, this triple-combination formulation guarantees pharmaceutical-grade purity across all three actives
• Additionally, the single-capsule format simplifies dosing and supports patient adherence
• Furthermore, each capsule delivers precise, validated dosage accuracy at 40mg + 75mg + 75mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light and moisture
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, cardiology clinics, and pharmacies